194 related articles for article (PubMed ID: 34347287)
1. Factors impacting the time to ovarian cancer diagnosis based on classic symptom presentation in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Giordano SH; Meyer LA
Cancer; 2021 Nov; 127(22):4151-4160. PubMed ID: 34347287
[TBL] [Abstract][Full Text] [Related]
2. Temporal trends of healthcare system use between symptomatic presentation and ovarian cancer diagnosis in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; He W; Primm K; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2022 Jul; 32(7):899-905. PubMed ID: 35331992
[TBL] [Abstract][Full Text] [Related]
3. Association between time to diagnosis, time to treatment, and ovarian cancer survival in the United States.
Huepenbecker SP; Sun CC; Fu S; Zhao H; Primm K; Rauh-Hain JA; Fleming ND; Giordano SH; Meyer LA
Int J Gynecol Cancer; 2022 Sep; 32(9):1153-1163. PubMed ID: 36166208
[TBL] [Abstract][Full Text] [Related]
4. Ovarian cancer: can we make the clinical diagnosis earlier?
Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
[TBL] [Abstract][Full Text] [Related]
5. Time to diagnosis of Type I or II invasive epithelial ovarian cancers: a multicentre observational study using patient questionnaire and primary care records.
Lim A; Mesher D; Gentry-Maharaj A; Balogun N; Widschwendter M; Jacobs I; Sasieni P; Menon U
BJOG; 2016 May; 123(6):1012-20. PubMed ID: 26032603
[TBL] [Abstract][Full Text] [Related]
6. Symptom presentation in invasive ovarian carcinoma by tumor histological type and grade in a multiethnic population: a case analysis.
Lurie G; Wilkens LR; Thompson PJ; Matsuno RK; Carney ME; Goodman MT
Gynecol Oncol; 2010 Nov; 119(2):278-84. PubMed ID: 20591474
[TBL] [Abstract][Full Text] [Related]
7. Symptoms, diagnoses, and time to key diagnostic procedures among older U.S. women with ovarian cancer.
Ryerson AB; Eheman C; Burton J; McCall N; Blackman D; Subramanian S; Richardson LC
Obstet Gynecol; 2007 May; 109(5):1053-61. PubMed ID: 17470582
[TBL] [Abstract][Full Text] [Related]
8. Ovarian cancer outcomes: Predictors of early death.
Urban RR; He H; Alfonso R; Hardesty MM; Gray HJ; Goff BA
Gynecol Oncol; 2016 Mar; 140(3):474-80. PubMed ID: 26743531
[TBL] [Abstract][Full Text] [Related]
9. Ovarian cancer: the neglected diagnosis.
Yawn BP; Barrette BA; Wollan PC
Mayo Clin Proc; 2004 Oct; 79(10):1277-82. PubMed ID: 15473410
[TBL] [Abstract][Full Text] [Related]
10. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
[TBL] [Abstract][Full Text] [Related]
11. Histological Tumor Type is Associated with One-Year Cause-Specific Survival in Women with Stage III-IV Epithelial Ovarian Cancer: A Surveillance, Epidemiology, and End Results (SEER) Database Population Study, 2004-2014.
Wu SG; Li FY; Lei J; Hua L; He ZY; Zhou J
Med Sci Monit; 2020 Feb; 26():e920531. PubMed ID: 32008036
[TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy in the Medicare cohort with advanced ovarian cancer.
Thrall MM; Gray HJ; Symons RG; Weiss NS; Flum DR; Goff BA
Gynecol Oncol; 2011 Dec; 123(3):461-6. PubMed ID: 21945309
[TBL] [Abstract][Full Text] [Related]
13. Ovarian cancer symptoms, routes to diagnosis and survival - Population cohort study in the 'no screen' arm of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).
Dilley J; Burnell M; Gentry-Maharaj A; Ryan A; Neophytou C; Apostolidou S; Karpinskyj C; Kalsi J; Mould T; Woolas R; Singh N; Widschwendter M; Fallowfield L; Campbell S; Skates SJ; McGuire A; Parmar M; Jacobs I; Menon U
Gynecol Oncol; 2020 Aug; 158(2):316-322. PubMed ID: 32561125
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of upfront treatment strategies in elderly women with ovarian cancer.
Wright JD; Ananth CV; Tsui J; Glied SA; Burke WM; Lu YS; Neugut AI; Herzog TJ; Hershman DL
Cancer; 2014 Apr; 120(8):1246-54. PubMed ID: 24443159
[TBL] [Abstract][Full Text] [Related]
15. Identification of ovarian cancer symptoms in health insurance claims data.
Devlin SM; Diehr PH; Andersen MR; Goff BA; Tyree PT; Lafferty WE
J Womens Health (Larchmt); 2010 Mar; 19(3):381-9. PubMed ID: 20156131
[TBL] [Abstract][Full Text] [Related]
16. Costs of treatment for elderly women with advanced ovarian cancer in a Medicare population.
Forde GK; Chang J; Ziogas A; Tewari K; Bristow RE
Gynecol Oncol; 2015 Jun; 137(3):479-84. PubMed ID: 25866323
[TBL] [Abstract][Full Text] [Related]
17. Statin treatment is associated with survival in a nationally representative population of elderly women with epithelial ovarian cancer.
Vogel TJ; Goodman MT; Li AJ; Jeon CY
Gynecol Oncol; 2017 Aug; 146(2):340-345. PubMed ID: 28596017
[TBL] [Abstract][Full Text] [Related]
18. Algorithm to Identify Incident Epithelial Ovarian Cancer Cases Using Claims Data.
Huepenbecker SP; Zhao H; Sun CC; Fu S; He W; Giordano SH; Meyer LA
JCO Clin Cancer Inform; 2022 Mar; 6():e2100187. PubMed ID: 35297648
[TBL] [Abstract][Full Text] [Related]
19. Predictive value of symptoms for early detection of ovarian cancer.
Rossing MA; Wicklund KG; Cushing-Haugen KL; Weiss NS
J Natl Cancer Inst; 2010 Feb; 102(4):222-9. PubMed ID: 20110551
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis-shift between low-grade serous ovarian cancer and serous borderline ovarian tumor: A population-based study.
Matsuo K; Machida H; Grubbs BH; Matsuzaki S; Klar M; Roman LD; Sood AK; Gershenson DM
Gynecol Oncol; 2020 Apr; 157(1):21-28. PubMed ID: 31954535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
